Back to top

Tale of the Tape

Zacks Equity Research

Investors are Betting Against Questcor Pharmaceuticals Inc (QCOR), Should You?
August 26, 2013

Save at Trade

Many investors appear to be quite bearish on Questcor Pharmaceuticals Inc , especially if you look at the percentage of the float that is sold short for this stock. Currently, 27.10% of the float is sold short, suggesting an extreme level of bearishness for QCOR.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #1(Strong Buy) on QCOR, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of QCOR to move higher in the weeks ahead.